Annual CFO
-$5.63 M
+$36.03 M+86.49%
31 December 2023
Summary:
Castle Biosciences annual cash flow from operations is currently -$5.63 million, with the most recent change of +$36.03 million (+86.49%) on 31 December 2023. During the last 3 years, it has fallen by -$15.49 million (-157.03%). CSTL annual CFO is now -157.03% below its all-time high of $9.87 million, reached on 31 December 2020.CSTL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$23.34 M
-$660.00 K-2.75%
30 September 2024
Summary:
Castle Biosciences quarterly cash flow from operations is currently $23.34 million, with the most recent change of -$660.00 thousand (-2.75%) on 30 September 2024. Over the past year, it has increased by +$18.33 million (+365.64%). CSTL quarterly CFO is now -2.75% below its all-time high of $24.00 million, reached on 30 June 2024.CSTL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$59.09 M
+$18.33 M+44.96%
30 September 2024
Summary:
Castle Biosciences TTM cash flow from operations is currently $59.09 million, with the most recent change of +$18.33 million (+44.96%) on 30 September 2024. Over the past year, it has increased by +$89.30 million (+295.57%). CSTL TTM CFO is now at all-time high.CSTL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +86.5% | +365.6% | +295.6% |
| 3 y3 years | -157.0% | +480.5% | +455.3% |
| 5 y5 years | +54.2% | +3003.5% | +8680.9% |
CSTL Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -157.0% | +86.5% | -2.8% | +191.7% | at high | +229.4% |
| 5 y | 5 years | -157.0% | +86.5% | -2.8% | +191.7% | at high | +229.4% |
| alltime | all time | -157.0% | +86.5% | -2.8% | +191.7% | at high | +229.4% |
Castle Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.34 M(-2.8%) | $59.09 M(+45.0%) |
| June 2024 | - | $24.00 M(-451.1%) | $40.76 M(+214.1%) |
| Mar 2024 | - | -$6.83 M(-136.8%) | $12.98 M(-330.7%) |
| Dec 2023 | -$5.63 M(-86.5%) | $18.59 M(+270.8%) | -$5.63 M(-81.4%) |
| Sept 2023 | - | $5.01 M(-232.4%) | -$30.21 M(-25.3%) |
| June 2023 | - | -$3.79 M(-85.1%) | -$40.45 M(-11.4%) |
| Mar 2023 | - | -$25.44 M(+324.0%) | -$45.66 M(+9.6%) |
| Dec 2022 | -$41.66 M(+119.4%) | -$6.00 M(+14.9%) | -$41.66 M(+8.4%) |
| Sept 2022 | - | -$5.22 M(-42.0%) | -$38.44 M(-2.3%) |
| June 2022 | - | -$9.00 M(-58.0%) | -$39.34 M(+7.0%) |
| Mar 2022 | - | -$21.43 M(+670.6%) | -$36.78 M(+93.8%) |
| Dec 2021 | -$18.98 M | -$2.78 M(-54.7%) | -$18.98 M(+14.1%) |
| Sept 2021 | - | -$6.13 M(-4.7%) | -$16.63 M(+23.6%) |
| June 2021 | - | -$6.44 M(+77.3%) | -$13.45 M(-307.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$3.63 M(+744.4%) | $6.49 M(-34.3%) |
| Dec 2020 | $9.87 M(+40.6%) | -$430.00 K(-85.4%) | $9.87 M(-33.3%) |
| Sept 2020 | - | -$2.96 M(-121.9%) | $14.79 M(-20.0%) |
| June 2020 | - | $13.50 M(-5478.9%) | $18.50 M(+237.7%) |
| Mar 2020 | - | -$251.00 K(-105.6%) | $5.48 M(-21.9%) |
| Dec 2019 | $7.01 M(-157.1%) | $4.49 M(+497.5%) | $7.01 M(-1118.7%) |
| Sept 2019 | - | $752.00 K(+56.0%) | -$688.60 K(-79.3%) |
| June 2019 | - | $482.00 K(-62.6%) | -$3.32 M(-60.9%) |
| Mar 2019 | - | $1.29 M(-140.1%) | -$8.50 M(-30.9%) |
| Dec 2018 | -$12.29 M(+0.5%) | -$3.21 M(+70.9%) | -$12.29 M(+35.3%) |
| Sept 2018 | - | -$1.88 M(-60.0%) | -$9.08 M(+26.1%) |
| June 2018 | - | -$4.70 M(+87.2%) | -$7.21 M(+187.2%) |
| Mar 2018 | - | -$2.51 M | -$2.51 M |
| Dec 2017 | -$12.23 M | - | - |
FAQ
- What is Castle Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Castle Biosciences?
- What is Castle Biosciences annual CFO year-on-year change?
- What is Castle Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Castle Biosciences?
- What is Castle Biosciences quarterly CFO year-on-year change?
- What is Castle Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Castle Biosciences?
- What is Castle Biosciences TTM CFO year-on-year change?
What is Castle Biosciences annual cash flow from operations?
The current annual CFO of CSTL is -$5.63 M
What is the all time high annual CFO for Castle Biosciences?
Castle Biosciences all-time high annual cash flow from operations is $9.87 M
What is Castle Biosciences annual CFO year-on-year change?
Over the past year, CSTL annual cash flow from operations has changed by +$36.03 M (+86.49%)
What is Castle Biosciences quarterly cash flow from operations?
The current quarterly CFO of CSTL is $23.34 M
What is the all time high quarterly CFO for Castle Biosciences?
Castle Biosciences all-time high quarterly cash flow from operations is $24.00 M
What is Castle Biosciences quarterly CFO year-on-year change?
Over the past year, CSTL quarterly cash flow from operations has changed by +$18.33 M (+365.64%)
What is Castle Biosciences TTM cash flow from operations?
The current TTM CFO of CSTL is $59.09 M
What is the all time high TTM CFO for Castle Biosciences?
Castle Biosciences all-time high TTM cash flow from operations is $59.09 M
What is Castle Biosciences TTM CFO year-on-year change?
Over the past year, CSTL TTM cash flow from operations has changed by +$89.30 M (+295.57%)